Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Howard

Showing results (231-240 of 266) with videos related to

Pageof 27
Sort By:
Health Technology Assessment (Winchester, England)|December 4, 2018
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCTRobert Howard, Elizabeth Cort, Rosie Bradley, et al.
BMJ Open|October 11, 2014
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's diseaseBrian Lawlor, Sean Kennelly, Sarah O'Dwyer, et al.
Lancet (London, England)|July 25, 2017
Dementia prevention, intervention, and careGill Livingston, Andrew Sommerlad, Vasiliki Orgeta, et al.
International Journal of Geriatric Psychiatry|October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)Martin Knapp, Derek King, Renée Romeo, et al.
Health Technology Assessment (Winchester, England)|April 11, 2025
Lessons from the PROTECT-CH COVID-19 platform trial in care homesPhilip M Bath, Jonathan Ball, Matthew Boyd, et al.
International Journal of Geriatric Psychiatry|September 18, 2010
Determining the minimum clinically important differences for outcomes in the DOMINO trialRobert Howard, Patrick Phillips, Tony Johnson, et al.
Brain : a Journal of Neurology|August 16, 2021
Reply: Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
The Lancet. Neurology|October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Rupert McShane, James Lindesay, et al.
Age and Ageing|January 25, 2021
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trialRobert Howard, Rebecca Gathercole, Rosie Bradley, et al.
Journal of Aerosol Science|August 11, 2022
Assessment of a regulatory measurement system for the determination of the non-volatile particulate matter emissions from commercial aircraft enginesJohn S Kinsey, Robert Giannelli, Robert Howard, et al.
Pageof 27

Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
Health Technology Assessment (Winchester, England)|December 4, 2018
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCTRobert Howard, Elizabeth Cort, Rosie Bradley, et al.
BMJ Open|October 11, 2014
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's diseaseBrian Lawlor, Sean Kennelly, Sarah O'Dwyer, et al.
Lancet (London, England)|July 25, 2017
Dementia prevention, intervention, and careGill Livingston, Andrew Sommerlad, Vasiliki Orgeta, et al.
International Journal of Geriatric Psychiatry|October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)Martin Knapp, Derek King, Renée Romeo, et al.
Health Technology Assessment (Winchester, England)|April 11, 2025
Lessons from the PROTECT-CH COVID-19 platform trial in care homesPhilip M Bath, Jonathan Ball, Matthew Boyd, et al.
International Journal of Geriatric Psychiatry|September 18, 2010
Determining the minimum clinically important differences for outcomes in the DOMINO trialRobert Howard, Patrick Phillips, Tony Johnson, et al.
Brain : a Journal of Neurology|August 16, 2021
Reply: Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
The Lancet. Neurology|October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Rupert McShane, James Lindesay, et al.
Age and Ageing|January 25, 2021
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trialRobert Howard, Rebecca Gathercole, Rosie Bradley, et al.
Journal of Aerosol Science|August 11, 2022
Assessment of a regulatory measurement system for the determination of the non-volatile particulate matter emissions from commercial aircraft enginesJohn S Kinsey, Robert Giannelli, Robert Howard, et al.
Pageof 27